MMMELD-XI Score Is Associated With Short-Term Adverse Events in Patients With Heart Failure With Preserved Ejection

Sunying Wang1, Yuwei Wang1, Manqing Luo1

  • 1Department of Cardiology, Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.

Insights

The MELD-XI score can predict short-term adverse outcomes in patients hospitalized with heart failure with preserved ejection fraction (HFpEF). This score offers valuable insights for risk stratification in HFpEF prognosis.

Area of Science:

  • Cardiology
  • Nephrology
  • Hepatology

Background:

  • The Model for End-Stage Liver Disease-XI (MELD-XI) score is increasingly recognized for its prognostic value in congestive heart failure.
  • Existing evidence primarily focuses on end-stage heart failure populations, necessitating research in other heart failure phenotypes.
  • Heart failure with preserved ejection fraction (HFpEF) represents a distinct clinical entity with unique prognostic factors.

Purpose of the Study:

  • To investigate the association between the MELD-XI score and prognosis in patients hospitalized with HFpEF.
  • To determine if the MELD-XI score can predict short-term adverse events, including mortality and rehospitalization, in this population.
  • To assess the incremental value of the MELD-XI score in existing risk stratification models for HFpEF.

Main Methods:

  • A retrospective cohort study involving 30,096 patients hospitalized for HFpEF.
  • Data collected from Fujian Provincial Hospital between January 1, 2014, and July 17, 2020.
  • Primary endpoint: 60-day in-hospital all-cause mortality. Secondary endpoints: 60-day cardiovascular mortality and 30-day heart failure rehospitalization.

Main Results:

  • Elevated MELD-XI scores correlated with increased comorbidities, higher NYHA class, and elevated inflammatory biomarkers.
  • MELD-XI score showed positive correlations with NT-pro BNP, left atrial diameter, and E/e', and a negative correlation with LVEF.
  • After adjusting for confounders, MELD-XI score independently predicted 60-day all-cause mortality (HR 1.052), 60-day cardiovascular mortality (HR 1.064), and 30-day HF rehospitalization (HR 1.061).

Conclusions:

  • The MELD-XI score is significantly associated with adverse short-term outcomes in hospitalized HFpEF patients.
  • The MELD-XI score enhances the discriminatory capacity of risk stratification models for HFpEF.
  • This score may serve as a valuable tool for predicting prognosis and guiding management in HFpEF.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
60
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
98
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
118
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
133
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
111
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
104